Cowen analyst Tyler Van Buren raised the price target on Regeneron Pharma (NASDAQ: REGN) to $640.00 (from $625.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Regeneron (REGN) Results Highlight Strong Fundamentals, Focus Remains on Novel Product Readouts - BMO CapitalFebruary 4, 2022 3:04 PM Regeneron (REGN) Beats Estimates, Fueled by Covid Therapy and EyleaFebruary 4, 2022 10:04 AM Form 8-K REGENERON PHARMACEUTICAL For: Feb 04February 4, 2022 7:30 AM Regeneron revenue beats estimates on strong sales of Eylea, COVID therapyFebruary 4, 2022 6:38 AM Regeneron (REGN) Tops Q4 EPS by $5.35February 4, 2022 6:31 AM Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating ResultsFebruary 4, 2022 6:30 AM